EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Great Transatlantic Divide: The Case of Experimental Neuropharmacology

Carlo Colosimo

Clinical Drug Investigation · 2026-11 · 46 (11) · 1209-1212

DOI: 10.1007/s40261-026-01593-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Drug Investigation, online erschienen am 08.09.2026. Verfasst von Carlo Colosimo. Beteiligte Einrichtung: Department of Neurology, LUM University, "F. Miulli" Regional General Hospital, 70021, Acquaviva delle Fonti, Bari, Italy. colosimo@lum.it. Hauptthemen laut MEDLINE: Drug Approval, Neuropharmacology, Nervous System Diseases. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite substantial agreement between the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) on new drug approval in the past decades, a few new drugs for the treatment of some of the most prevalent and severe neurological disorders, such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis, as well as much rarer neurogenetic disorders, were handled differently by the two regulatory agencies. The possible reasons for the differing behaviors of the FDA and EMA are several and wide-ranging, and they will be examined in this opinion-based analysis. How patients’ perceptions of the complex approaches to drug approval and commercialization may create disappointment and confusion will also be reappraised.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug ApprovalNeuropharmacologyNervous System DiseasesHumansUnited StatesUnited States Food and Drug AdministrationAnimalsEurope

Autor:innen und Institutionen

  • Department of Neurology, LUM University, "F. Miulli" Regional General Hospital, 70021, Acquaviva delle Fonti, Bari, Italy. colosimo@lum.it.

Zitieren

APA

Colosimo, C. (2026). The Great Transatlantic Divide: The Case of Experimental Neuropharmacology. Clinical Drug Investigation, 46(11), 1209-1212. https://doi.org/10.1007/s40261-026-01593-5

Vancouver

Colosimo C. The Great Transatlantic Divide: The Case of Experimental Neuropharmacology. Clinical Drug Investigation. 2026;46(11):1209-1212. doi:10.1007/s40261-026-01593-5

BibTeX
@article{Colosimo2026,
  author = {Colosimo, Carlo},
  title = {The Great Transatlantic Divide: The Case of Experimental Neuropharmacology},
  journal = {Clinical Drug Investigation},
  year = {2026},
  volume = {46},
  number = {11},
  pages = {1209--1212},
  doi = {10.1007/s40261-026-01593-5}
}
Kostenlos starten →